Bioequivalence of Dapagliflozin 10 mg Tablets Under Fasting Conditions
Clinical trial NCT04880993 · COMPLETED
Trial details
- NCT number
- NCT04880993
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2020-12-24
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.